| Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparison | Protocol: BRCA2 generic BayesDel threshold evidence-code assignment Dataset: BRCA2 functional reference calibration set | <10% Proportion (benign reference variants assigned BP4) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 generic BayesDel threshold comparator Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants |
|---|
| Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparison | Protocol: BRCA2 generic BayesDel threshold evidence-code assignment Dataset: BRCA2 functional reference calibration set | 36% Proportion (benign reference variants assigned PP3) percent · lower Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 generic BayesDel threshold comparator Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3 |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 29 Count (interval: high, benign) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 10% Proportion (interval: high, benign) percent · lower Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_fraction |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 6.59 Likelihood ratio (interval: high) unitless · unknown Uncertainty: 95% CI 4.40 to 9.90 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, likelihood_ratio |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 88 Count (interval: high, pathogenic) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 66% Proportion (interval: high, pathogenic) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_fraction |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 216 Count (interval: low, benign) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, benign_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 74% Proportion (interval: low, benign) percent · higher Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, benign_fraction |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 0.21 Likelihood ratio (interval: low) unitless · unknown Uncertainty: 95% CI 0.14 to 0.33 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, likelihood_ratio |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 21 Count (interval: low, pathogenic) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, pathogenic_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 16% Proportion (interval: low, pathogenic) percent · lower Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, pathogenic_fraction |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 46 Count (interval: middle, benign) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, benign_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 16% Proportion (interval: middle, benign) percent · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, benign_fraction |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 1.18 Likelihood ratio (interval: middle) unitless · unknown Uncertainty: 95% CI 0.73 to 1.90 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, likelihood_ratio |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 25 Count (interval: middle, pathogenic) count · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, pathogenic_count |
|---|
| Configuration: BayesDel with ENIGMA BRCA gene-specific score categories | Protocol: BRCA2 BayesDel evidence calibration Dataset: BRCA2 functional reference calibration set | 19% Proportion (interval: middle, pathogenic) percent · unknown Uncertainty: Not reported by the source: not reported for this endpoint Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceBRCA2 BayesDel gene-specific calibration Not reported Aggregation: Not reported Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, pathogenic_fraction |
|---|